Tag: Genvoya

February 15, 2017 Off

Gilead reports results from HIV treatment study at CROI 2017

Gilead Sciences has announced data from two Phase 3 studies evaluating the safety and efficacy of Genvoya for the treatment of HIV-1 infection in treatment-naïve adults.

November 6, 2015 Off

FDA approves Genvoya

By Dino Mustafić

FDA has approved Genvoya, a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide.